Health

J&J COVID-19 vaccine protects against breakthrough infections, study says – National

Johnson & Johnson said on Thursday that a real-world study showed its single-shot COVID-19 vaccine protects against breakthrough infections and hospitalizations for up to six months.

The study, sponsored by the vaccine developer, was conducted between Jan. 1 and Sept. 7 last year, before the Omicron variant was discovered. It is also yet to be peer-reviewed.

Read more:

COVID-19 vaccine maker Johnson & Johnson splitting into two companies

J&J said protection against infection from its single dose vaccine starts to wane only from the fourth month compared to the second month in the case of two-dose vaccines from rivals Pfizer Inc and BioNTech’s as well as Moderna .

No waning of protection was found for ICU admissions for all the three vaccines, J&J said. The company said the study was carried out by collecting claims and laboratory data covering 168 million people.

Story continues below advertisement


Click to play video: 'U.S. doctors fear COVID-19 cases will surge after holidays'







U.S. doctors fear COVID-19 cases will surge after holidays


U.S. doctors fear COVID-19 cases will surge after holidays

 




Source link

Leave a Reply

Your email address will not be published. Required fields are marked *